Altogether these data unveiled cancer-like deficits in SGS NPCs with loss of cell proliferation control, DNA damage accumulation, hypoactivation of P53 signaling, and lack of apoptosis activation, associated with dysregulation of genes and pathways related to tumorigenesis. The gene discussed is TP53; the disease is cancer.